Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
No specific host molecular target is a pharmacological classification for drugs that do not achieve their therapeutic effect by binding to a specific host protein, such as a receptor, enzyme, or transporter (DrugBank, 2024). Instead, these agents act through non-specific physical or chemical interactions within the body. Common examples include antacids, which neutralize gastric acid through simple chemical reactions, and osmotic diuretics like mannitol, which create an osmotic gradient to promote fluid excretion (StatPearls, 2023). Other substances in this category include adsorbents like activated charcoal that physically bind toxins and chelating agents that sequester metal ions (NCBI Bookshelf, 2023). Because these mechanisms are governed by the drug's physical properties rather than a specific lock-and-key molecular fit, they often have broad physiological impacts and are less susceptible to target-site mutations. This classification is essential for identifying drugs whose mechanisms of action fall outside the traditional receptor-mediated paradigm of drug discovery.
The mechanism of action for drugs in this category involves non-specific physical or chemical processes, such as the chemical neutralization of acids, the creation of osmotic gradients, the physical adsorption of molecules, or the chelation of metal ions (DrugBank, 2024; StatPearls, 2023).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on No specific host molecular target.